Total
0
Shares
Opyl (ASX:OPL) - CEO, Michelle Gallaher - The Market Herald - The Market Herald
CEO, Michelle Gallaher
Sourced: Startup Daily
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Medical tech support company Opyl (OPL) has completed an off-market share buy-back facility for eligible shareholders who held unmarketable parcels in the company as of February 18
  • Shareholders had until April 6 to either opt-out of the facility or increase their shareholding to more than a marketable parcel
  • Those who exercised neither option by the closing time had their shares bought-back by Opyl at 17.7 cents per share
  • The buy-back price was equal to the volume-weighted average price for the five-day trading period preceding the closing date
  • All up, Opyl has acquired and cancelled more than 370,000 shares through the facility
  • The company will advise eligible shareholders of any relevant remittance of shares as soon as practicable after April 16
  • Opyl shares are in the grey, last trading at 20.5 cents each

Medical tech support provider Opyl (OPL) has completed an off-market share buy-back facility for eligible shareholders who held unmarketable parcels in the company as of February 18.

Based in Melbourne, Opyl provides biopharma and health organisations access to emerging automated intelligence-assisted technologies and data insights to improve healthcare design, development and delivery.

The company gave impacted shareholders until April 6 to either opt-out of the facility or increase their shareholding to more than a marketable parcel.

Those shareholders who chose not to exercise either option by the closing time had their shares bought-back by Opyl at 17.7 cents per share.

The buy-back price equalled the volume-weighted average price for the five-day trading period preceding the closing date.

All up, Opyl has acquired and cancelled more than 370,000 shares through the facility.

OPL says it will advise eligible shareholders of any relevant remittance of shares as soon as practicable after April 16.

Last month, Opyl received commitments for a $1.38 million share placement aimed at accelerating company growth.

Opyl shares are in the grey, last trading at 20.5 cents at 12:31 pm AEST.

OPL by the numbers
More From The Market Herald
Immutep (ASX:IMM) - CEO, Marc Voigt - The Market Herald

" Immutep (ASX:IMM) progresses multiple efti trials

Immutep (IMM) has provided an update on its clinical and preclinical programs.
PolyNovo (ASX:PNV) dispatches first NovoSorb BTM order in Europe

" Polynovo (ASX:PNV) appoints Joshua Cheetam as Director of Research and Development

PolyNovo (PNV) has appointed Dr Joshua Cheetam as Director of Research and Development.
The Market Herald Video

" Regeneus (ASX:RGS) secures $4.5 M for osteoarthritis trials

Clinical-stage regenerative medicine company Regeneus (RGS) has secured up to $4.5 million in a three-stage placement of the company’s shares to New Lif…
Xped (ASX:XPE) appoints Con Unerkov as CEO

" Flexiroam (ASX:FRX) leadership shuffle to underpin further growth

Mobile data provider Flexiroam (FRX) has announced several changes to the company’s board and leadership.